Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061466) titled 'Observational study of newly detected gastric cancer after intensive esophagogastroduodenoscopy (I-EGD) in high-risk populations' on May 11.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University Graduate School of Medicine
Condition:
Condition - Gastric cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the long-term cumulative incidence and clinicopathological characteristics of newly detected gastric cancer after intensive esophagogastroduodenoscopy (I-EGD) in patients who completed the WLI/2G-NBI protocol in the EGC Detection Trial (UMIN000014503)
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients who were enrolled in the EGC Detection Trial.
Key exclusion criteria - 1. Patients who did not complete protocol-defined intensive esophagogastroduodenoscopy (I-EGD) using white light imaging (WLI) and second-generation narrow band imaging (2G-NBI) in the EGC Detection Trial.
2. Patients for whom information on post-I-EGD esophagogastroduodenoscopy is unavailable.
3. Patients who opted out of the use of their clinical information for this study.
Target Size - 4400
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2023 Year 12 Month 25 Day
Date of IRB - 2024 Year 02 Month 29 Day
Anticipated trial start date - 2024 Year 02 Month 29 Day
Last follow-up date - 2025 Year 08 Month 11 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070333
Disclaimer: Curated by HT Syndication.
